Applications — HPLCmart

Classification

Compound

Mode

More criteria

Column vendor

Length, mm

Int. diameter, mm

Particle size, μm

Pore size, Å

Found 4,302

Already have a column?

Column name

Showing 4,302 applications

Sort by:

ID	Classification	Compounds	Linked columns
PDF 2119	Drugs Pharmaceuticals	6 compounds Amitriptyline Clomipramine Desipramine Doxepine Imipramine Nortriptyline	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2118	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2117	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2116	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2115	Antibiotics Pharmaceuticals	5 compounds Cefachlor Cefadroxil Cefazoline Cephalexin Cephradine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2114	Drugs Pharmaceuticals	1 compounds Chlorpheniramine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2113	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2112	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2111	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2110	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2109	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2108	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2107	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2106	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2105	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2104	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2103	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2102	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2101	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propanolol	Phenomenex Gemini-NX C18 100 × 21.2 mm · 5.0 µm
PDF 2100	Drugs Pharmaceuticals	2 compounds Naphazoline Pheniramine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2099	Drugs Pharmaceuticals	4 compounds Methylparaben Phenylephrine Phenylpropanolamine Pseudoephedrine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2098	Drugs Pharmaceuticals	4 compounds Methylephedrine Phenylephrine Phenylpropanolamine Pseudoephedrine	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2097	Drugs Pharmaceuticals	3 compounds Metoprolol Pindolol Propanolol	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2096	Drugs Pharmaceuticals	5 compounds Diphenhydramine Lidocaine Protriptyline Tetracaine Triprolidine	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2095	Drugs Pharmaceuticals	4 compounds Diflunisal Ibuprofen Indomethacin Naproxen	Phenomenex Gemini C6-Phenyl 150 × 4.6 mm · 5.0 µm
PDF 2094	Drugs Pharmaceuticals	3 compounds Amitriptyline Clomipramine Imipramine	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2093	Drugs Pharmaceuticals	2 compounds Diltiazem Promethazine	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2092	Drugs Pharmaceuticals	5 compounds Acetaminophen Chlorpheniramine Dextromethorphan Maleic acid Phenylephrine	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2091	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2090	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2089	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2088	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propanolol	Phenomenex Gemini-NX C18 250 × 21.2 mm · 5.0 µm
PDF 2087	Amines Pharmaceuticals	3 compounds Diphenhydramine Doxylamine Scopalamine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2086	Hormones Pharmaceuticals	5 compounds 11-alpha-Hydroxyprogesterone 17-alpha-Hydroxyprogesterone Dexamethasone Hydrocortisone Progesterone	Phenomenex Synergi Max-RP 50 × 4.6 mm · 4.0 µm
PDF 2085	Narcotics Pharmaceuticals	4 compounds Amphetamine Guaifenesin Methamphetamine Phenylpropranolamine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2084	Pharmaceuticals	5 compounds Acetophenone Caffeine Dimethylphthalate Phenol Thiourea	Phenomenex Synergi Polar-RP 50 × 4.6 mm · 4.0 µm
PDF 2083	Drugs Pharmaceuticals	5 compounds Ethylparaben Metaproterenol Metoprolol Pindolol Propranolol	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2082	Parabenes Pharmaceuticals	4 compounds Butyl Paraben Ethyl Parabene Methyl Parabene Propylparaben	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2081	Drugs Pharmaceuticals	15 compounds 2-hydroxy 5-methyl benzaldehyde 3-Methyl.4-nitrobenzoic acid Acebutolol Acetaminophen Benzyl alcohol Chlorpheniramine Diflunisal Hexanophenone Nortriptyline Phenol Pindolol Prednisolone Pyridine Sulfathiazole Triprolidine	Phenomenex Kinetex C18 100 × 2.1 mm · 1.7 µm
PDF 2080	Drugs Pharmaceuticals	15 compounds 2-hydroxy 5-methyl benzaldehyde 3-Methyl.4-nitrobenzoic acid Acebutolol Acetaminophen Benzyl alcohol Chlorpheniramine Diflunisal Hexanophenone Nortriptyline Phenol Pindolol Prednisolone Pyridine Sulfathiazole Triprolidine	Phenomenex Kinetex C18 100 × 2.1 mm · 2.6 µm
PDF 2079	Drugs Pharmaceuticals	13 compounds 2-hydroxy 5-methyl benzaldehyde 3-Methyl.4-nitrobenzoic acid Acebutolol Acetaminophen Benzylalcholol Chlorpheniramine Diflunisal Hexanophenone Nortriptyline Pindolol then Sulfathiazole Prednisolone Pyridine Triprolidine then Phenol	Phenomenex Kinetex C18 100 × 2.1 mm · 2.6 µm
PDF 2078	Drugs Pharmaceuticals	12 compounds 2-hydroxy 5-methyl benzaldehyde 3-Methyl.4-nitrobenzoic acid Acetominophene Benzyl alcohol Chlorpheniramine Diflunisal Hexanophenone Phenol + Acebutolol Pindolol Pyridine Sulfathiazole Triprolidine	Phenomenex Kinetex C18 100 × 4.6 mm · 2.6 µm
PDF 2077	Drugs Pharmaceuticals	14 compounds 2-hydroxy 5-methyl benzaldehyde 3-Methyl.4-nitrobenzoic acid Acebutolol Acetaminophen Benzyl alcohol Chlorpheniramine Diflunisal Hexanophenone Phenol Pindolol Prednisolone Pyridine Sulfathiazole Triprolidine	Phenomenex Kinetex C18 100 × 4.6 mm · 2.6 µm
PDF 2076	Antibiotics Pharmaceuticals	3 compounds Chloramphenicol 1 Chloramphenicol 2 D5-Chloramphenicol	Phenomenex Kinetex C18 50 × 2.1 mm · 2.6 µm
PDF 2075	Hormones Pharmaceuticals	11 compounds 21-Hydroxyprogesterone Alpha-estradiol Beta-estradiol Corticosterone Cortisone Acetate Deoxycorticosterone Estriol Estrone Hydrocortisone Prednisone Progesterone	Phenomenex Kinetex C18 50 × 4.6 mm · 2.6 µm
PDF 2074	Drugs Pharmaceuticals	9 compounds 1.3-Dinitronaphthalene 1.5-Dinitronaphthalene 2-hydroxy 5-methyl benzaldehyde 3-Methyl. 4-Nitrobenzaldehyde Acetominophene Anthracene Chlorpheniramine Pindolol Uracil	Phenomenex Kinetex XB-C18 50 × 4.6 mm · 2.6 µm
PDF 2073	Drugs Pharmaceuticals	4 compounds Acetaminophen Acetylsalicylic acid Benzoic Acid Caffeine	Phenomenex Kinetex C18 100 × 2.1 mm · 2.6 µm
PDF 2072	Drugs Pharmaceuticals	4 compounds Acetaminophen Acetylsalicylic acid Benzoic Acid Caffeine	Phenomenex Kinetex C18 100 × 2.1 mm · 1.7 µm
PDF 2071	Drugs Pharmaceuticals	2 compounds Lovastatin Simvastatin	Phenomenex Kinetex C18 150 × 4.6 mm · 2.6 µm
PDF 2070	Drugs Pharmaceuticals	2 compounds Lovastatin Simvastatin	Phenomenex Kinetex C18 100 × 2.1 mm · 2.6 µm

Showing 2,251–2,300 of 4,302

← Prev3839404142434445464748495051525354Next page →